Funder
Pharmaceutical Research and Manufacturers of America Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference19 articles.
1. Willke RJ, Neumann PJ, Garrison LP Jr, Ramsey SD. Review of recent US value frameworks-a health economics approach: an ISPOR Special Task Force Report [6]. Value Health. 2018;21(2):155–60.
2. CVS Health. Current and New Approaches to Making Drugs More Affordable 2018. https://cvshealth.com/sites/default/files/cvs-health-current-and-new-approaches-to-making-drugs-more-affordable.pdf. Accessed 20 Sept 2020.
3. Diaby V, Ali AA, Montero AJ. Value assessment frameworks in the united states: a call for patient engagement. Pharmacoecon Open. 2019;3(1):1–3.
4. Perfetto EM, Oehrlein EM, Boutin M, Reid S, Gascho E. Value to whom? The patient voice in the value discussion. Value Health. 2017;20(2):286–91.
5. Armstrong MJ, Mullins CD. Value assessment at the point of care: incorporating patient values throughout care delivery and a draft taxonomy of patient values. Value Health. 2017;20(2):292–5.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献